p.39 抽出テキスト

Arnett et al 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

September 10, 2019 Circulation. 2019;140:e596–e646. DOI: 10.1161/CIR.0000000000000678 e634

CLINICAL STATEMENTS AND GUIDELINES blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med. 2010;170:126–35. S4.4-66.	 Reboussin DM, Allen NB, Griswold ME, et al. Systematic review

for the 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/ NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71: e116–35. S4.4-67.	 Baker S, Priest P, Jackson R. Using thresholds based on risk of cardiovascular disease to target treatment for hypertension: modelling events averted and number treated. BMJ. 2000;320:680–5. S4.4-68.	 Eddy DM, Adler J, Patterson B, et al. Individualized guidelines: the potential for increasing quality and reducing costs. Ann Intern Med. 2011;154:627–34. S4.4-69.	 Karmali KN, Lloyd-Jones DM. Global risk assessment to guide blood pressure management in cardiovascular disease prevention. Hypertension. 2017;69:e2–9. S4.4-70.	 Muntner P, Whelton PK. Using predicted cardiovascular disease risk in conjunction with blood pressure to guide antihypertensive medication treatment. J Am Coll Cardiol. 2017;69:2446–56. S4.4-71.	 Brunström M, Carlberg B. Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses. BMJ. 2016;352:i717. S4.4-72.	 Appel LJ, Wright JT Jr, Greene T, et al. Intensive blood-pressure control in hypertensive chronic kidney disease. N Engl J Med. 2010;363:918–29. S4.4-73.	 Reboldi G, Gentile G, Angeli F, et al. Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73 913 patients. J Hypertens. 2011;29:1253–69. S4.4-74.	 Action to Control Cardiovascular Risk in Diabetes Study Group Gerstein HC, Miller ME, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59. S4.4-75.	 Julius S, Kaciroti N, Egan BM, et al. TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension. J Am Soc Hypertens. 2008;2:39–43. S4.4-76.	 Lüders S, Schrader J, Berger J, et al. The PHARAO study: prevention of hypertension with the angiotensin-converting enzyme inhibitor ramipril in patients with high-normal blood pressure: a prospective, randomized, controlled prevention trial of the German Hypertension League. J Hypertens. 2008;26:1487–96. S4.4-77.	 Allen NB, Siddique J, Wilkins JT, et al. Blood pressure trajectories in early adulthood and subclinical atherosclerosis in middle age. JAMA. 2014;311:490–7. S4.4-78.	 Inder JD, Carlson DJ, Dieberg G, et al. Isometric exercise training for blood pressure management: a systematic review and meta-analysis to optimize benefit. Hypertens Res. 2016;39:88–94. S4.4-79.	 Roerecke M, Kaczorowski J, Tobe SW, et al. The effect of a reduction in alcohol consumption on blood pressure: a systematic review and meta-analysis. Lancet Public Health. 2017;2:e108–20. S4.4-80.	 National Institute on Alcohol Abuse and Alcoholism. What Is A Standard Drink? Available at: https://www.niaaa.nih.gov/ alcohol-health/overview-alcohol-consumption/what-standard-drink. Accessed August 16, 2017. S4.4-81.	 National Heart, Lung, and Blood Institute. Your Guide to Lowering Your Blood Pressure With DASH—How Do I Make the DASH? Available at: https://health.gov/dietaryguidelines/dga2005/toolkit/ DASH/how_make_dash.htm. Accessed January 6, 2019. S4.4-82.	 Top 10 Dash Diet Tips. Available at: http://dashdiet.org/dash-diet-

tips.html. Accessed January 6, 2019.

4.5 Tobacco Use

S4.5-1.	 Carson KV, Verbiest MEA, Crone MR, et al. Training health professionals in smoking cessation. Cochrane Database Syst Rev. 2012:CD000214. S4.5-2.	 Patnode CD, Henderson JT, Thompson JH, et al. Behavioral coun-

seling and pharmacotherapy interventions for tobacco cessation in adults, including pregnant women: a review of reviews for the US Preventive Services Task Force. Ann Intern Med. 2015;163: 608–21. S4.5-3.	 Stead LF, Koilpillai P, Fanshawe TR1, et al. Combined pharmacother-

apy and behavioural interventions for smoking cessation. Cochrane Database Syst Rev. 2016;3:CD008286. S4.5-4.	 Pan A, Wang Y, Talaei M, et al. Relation of smoking with total mortality and cardiovascular events among patients with diabetes mellitus: a meta-analysis and systematic review. Circulation. 2015;132:1795–804. S4.5-5.	 Mons U, Müezzinler A, Gellert C, et al. Impact of smoking and smoking cessation on cardiovascular events and mortality among older adults: meta-analysis of individual participant data from prospective cohort studies of the CHANCES consortium. BMJ. 2015;350:h1551. S4.5-6.	 Lv X, Sun J, Bi Y, et al. Risk of all-cause mortality and cardiovascular disease associated with secondhand smoke exposure: a systematic review and meta-analysis. Int J Cardiol. 2015;199:106–15. S4.5-7.	 US National Center for Chronic Disease Prevention and Health Promotion Office on Smoking and Health. The Health Consequences of Smoking—50 Years of Progress: A Report of the Surgeon General. 2014. US Centers for Disease Control and Prevention: Atlanta, GA. Available at: http://www.ncbi.nlm.nih.gov/books/NBK179276. Accessed January 5, 2019. S4.5-8.	 Teo KK, Ounpuu S, Hawken S, et al. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a casecontrol study. Lancet. 2006;368:647–58. S4.5-9.	 US Department of Health and Human Services. Healthy People 2020. Washington, DC: 2010. Available at: https://www.healthypeople. gov. Accessed January 3, 2019. S4.5-10.	 Bhatnagar A, Whitsel LP, Ribisl KM, et al. Electronic cigarettes: a policy statement from the American Heart Association. Circulation. 2014;130:1418–36. S4.5-11.	 Bhatnagar A. cardiovascular perspective of the promises and perils of e-cigarettes. Circ Res. 2016;118:1872–5. S4.5-12.	 Lippi G, Favaloro EJ, Meschi T, et al. E-cigarettes and cardiovascular risk: beyond science and mysticism. Semin Thromb Hemost. 2014;40:60–5. S4.5-13.	 Moheimani RS, Bhetraratana M, Yin F, et al. Increased cardiac sympathetic activity and oxidative stress in habitual electronic cigarette users: implications for cardiovascular risk. JAMA Cardiol. 2017;2:278–84. S4.5-14.	 A clinical practice guideline for treating tobacco use and dependence: a US Public Health Service report. The Tobacco Use and Dependence Clinical Practice Guideline panel, staff, and consortium representatives. JAMA. 2000;283:3244–54. S4.5-15.	 Tobacco Use and Dependence Guideline Panel Treating Tobacco Use and Dependence: 2008 Update. Washington, DC: US Department of Health and Human Services, 2008. S4.5-16.	 Pbert L, Fletcher KE, Flint AJ, et al. Smoking prevention and cessation intervention delivery by pediatric providers, as assessed with patient exit interviews. Pediatrics. 2006;118:e810–24. S4.5-17.	 Wang M, Wang J-W, Cao S-S, et al. Cigarette smoking and electronic cigarettes use: a meta-analysis. Int J Environ Res Public Health. 2016;13:120. https://doi.org/10.3390/ijerph13010120. S4.5-18.	 Jha P, Ramasundarahettige C, Landsman V, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368:341–50. S4.5-19.	 Barua RS, Rigotti NA, Benowitz NL, et al. 2018 ACC Expert Consensus Decision Pathway on Tobacco Cessation Treatment: A Report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol. 2018;72:3332–65. S4.5-20.	 Anthenelli RM, Benowitz NL, West R, et al. Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind randomised, placebo-controlled clinical trial. Lancet. 2016;387:2507–20. S4.5-21.	 Prochaska JJ, Benowitz NL. The past, present, and future of nicotine addiction therapy. Annu Rev Med. 2016;67:467–86. S4.5-22.	 Rigotti NA, Clair C, Munafo MR, et al. Interventions for smoking cessation in hospitalised patients. Cochrane Database Syst Rev. 2012:CD001837. S4.5-23.	 US Preventive Services Task Force. Final Recommendation Statement:

Tobacco Smoking Cessation in Adults, Including Pregnant Women: Behavioral and Pharmacotherapy Interventions. 2017. Available at: https://www.uspreventiveservicestaskforce.org/Page/Document/ RecommendationStatementFinal/tobacco-use-in-adults-and-pregnantwomen-counseling-and-interventions1. Accessed January 5, 2019.

Downloaded from http://ahajournals.org by on October 7, 2026